ZAIPHYR
DEAD

Serial Number

86048204

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 26, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ZAIPHYR Trademark

Serial Number: 86048204

ZAIPHYR is a trademark filed by NOVARTIS AG on August 26, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 26, 2013

Registration Date

Not Registered

Published for Opposition

January 14, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 17, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 17, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2016 EXRA
SOU EXTENSION 5 GRANTED
Sep 10, 2016 EX5G
SOU EXTENSION 5 FILED
Sep 7, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 7, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2016 EXRA
SOU EXTENSION 4 GRANTED
Mar 15, 2016 EX4G
SOU EXTENSION 4 FILED
Mar 8, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 8, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2015 EXRA
SOU EXTENSION 3 GRANTED
Sep 14, 2015 EX3G
SOU EXTENSION 3 FILED
Sep 10, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 10, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 15, 2015 EXRA
SOU EXTENSION 2 GRANTED
Apr 14, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 14, 2015 AITU
SOU EXTENSION 2 FILED
Mar 9, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 9, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2014 EXRA
SOU EXTENSION 1 GRANTED
Sep 10, 2014 EX1G
SOU EXTENSION 1 FILED
Sep 10, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2013 CNSA
ASSIGNED TO EXAMINER
Dec 9, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2013 NWOS
NEW APPLICATION ENTERED
Aug 29, 2013 NWAP